Hemodialyzied kidney desease patients. Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: 80 mg Sina Curcumin medicine ? once in day in during 2months . Intervention 2: Control group: placebo contains 0/5 mg starch ? is given once in day during two mo
Prevention
Control group: placebo contains 0/5 mg starch ? is given once in day during two months.
Intervention group: 80 mg Sina Curcumin medicine ? once in day in during 2months .
Sponsors
Vice chancellor for research,Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
25 Years to 75 Years
Inclusion criteria
Inclusion criteria: IInclusion criteria: The patient's tendency to participating in study and signing approval form? Having a history of at least 6 months of dialysis? age between 25-75 years old ? BMI between 18.5 to 30? Lack of infectious disease, particularly hepatitis? Avoiding the use of no steroidal anti-inflammatory drugs, Nicotinic Acid, estrogen, progesterone and Curcumin supplementation for at least one month before the start of the study? Lack of drug addiction? Lack of severe heart disease, liver failure and thyroid, severe gastrointestinal bleeding and peptic ulcer disease, cholelithiasis, pregnancy or lactation Exclusion criteria: Increasing of potassium in patients' blood during the study? unwilling to continue to participate?Death of the patient? Performing kidney transplantation? Increasing in dose of anti-fat drugs? Changing patient's lifestyle or diet during the study? The use of herbal medicines for lipid lowering during the study? No adherence to study intervention of at least 9 tablets during two months of interference
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Trigliceride? Cholestrol? LDL? HDL ? hs crp. Timepoint: Before entrances and after entrances. Method of measurement: Blood test. | — |
Secondary
| Measure | Time frame |
|---|---|
| BUN? Cr? Serum Albumin ? Adequacy of Dialysis ? BMI. Timepoint: Before entrances and after entrance. Method of measurement: Blood test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDoctor Koushki
Sabzevar University of Medical Sciences
Outcome results
None listed